Literature DB >> 21897234

Nocturia: current status and future perspectives.

Philip Van Kerrebroeck1.   

Abstract

PURPOSE OF REVIEW: Nocturia is a bothersome and highly prevalent condition characterized by the need to wake to void at night. Nocturia is equally common in men and women, and although its prevalence increases with age, a significant proportion of younger people are also affected. Nocturia leads to fragmentation of sleep and consequently to a serious decline in daytime functioning and in quality of life and health. Its impact should not be underestimated by clinicians and therefore a review on nocturia is timely and relevant. RECENT
FINDINGS: Traditionally, nocturia is regarded as a symptom of benign prostatic enlargement and/or overactive bladder syndrome, with treatment therefore directed toward increasing the capacity of the bladder to hold urine. Such treatments have proven ineffective in many patients because nocturnal polyuria, an overproduction of urine at night, has been found to be present in the majority of patients. Nocturia can be attributed to some underlying pathological factors but it can also be a distinct clinical entity with specific pathogenesis. Frequency-volume charts are recommended for routine use in clinical practice, to determine whether nocturia is a result of excessive urine production at night, or of small voided volumes due to bladder problems, or a combination of these factors. Desmopressin, a synthetic analogue of the antidiuretic hormone, should be considered in patients with nocturia where nocturnal polyuria is present.
SUMMARY: Contrary to popular and medical misconception nocturia is an important condition leading to general morbidity and with serious impact on overall quality of life and health. We advise clinicians to pay attention to nocturia and diagnostics should be offered. Treatment modalities are available and have to be discussed with the patient. (C) 2011 Lippincott Williams & Wilkins, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897234     DOI: 10.1097/GCO.0b013e32834ac78c

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  6 in total

1.  Persistent polyuria in a rat spinal contusion model.

Authors:  Patricia J Ward; Charles H Hubscher
Journal:  J Neurotrauma       Date:  2012-08-27       Impact factor: 5.269

2.  Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).

Authors:  Richard Berges; Klaus Höfner; Michael Gedamke; Matthias Oelke
Journal:  World J Urol       Date:  2014-08-19       Impact factor: 4.226

3.  Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency.

Authors:  Jeffrey P Weiss; Zhanna Jumadilova; Theodore M Johnson; Mary P Fitzgerald; Martin Carlsson; Diane L Martire; Atul Malhotra
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

Review 4.  Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate.

Authors:  Stefan Ückert; George T Kedia; Dimitrios Tsikas; Annika Simon; Andreas Bannowsky; Markus A Kuczyk
Journal:  World J Urol       Date:  2019-09-10       Impact factor: 4.226

Review 5.  Medication adherence in the management of nocturia: challenges and solutions.

Authors:  Ravishankar Jayadevappa; Diane K Newman; Sumedha Chhatre; Alan J Wein
Journal:  Patient Prefer Adherence       Date:  2015-01-13       Impact factor: 2.711

Review 6.  A practical approach to the management of nocturia.

Authors:  Matthias Oelke; Stefan De Wachter; Marcus J Drake; Antonella Giannantoni; Mike Kirby; Susan Orme; Jonathan Rees; Philip van Kerrebroeck; Karel Everaert
Journal:  Int J Clin Pract       Date:  2017-10-05       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.